USC-Brookings Schaeffer on Health Policy
Featured Topics
Lead story
Other featured articles
-
Making Workplaces Better for People Struggling with Mental Health Will Make Work Better for Everyone
Making workplaces and jobs more flexible in time, space, and nature of interaction will be of immediate benefit to people with mental illnesses—and everyone else, too.
Posted in -
Comments On “A Bold Vision for America’s Mental Well Being”
This note represents a response to issues raised and the request for information associated with the white paper by Senators Bennet and Cornyn: “A bold vision for America’s mental well being.” Our discussion touches on several of the issues raised by the white paper. Specifically, we discuss work force challenges, financial alignment as it pertains to crisis response, the need for greater accountability, and the implications for existing financing programs. We highlight several points.
Posted in -
Paying for Cancer Drugs That Prove Their Benefit
The United States pays prices for brand-name drugs that are estimated to be 256% higher than other wealthy nations. As the accelerated approval of aducanumab for Alzheimer disease shows, high prices (announced price for aducanumab is $56 000 per year) extend to drugs that are promising but have not been shown by randomized clinical trials to provide long-term clinical benefits.
Posted in -
Cost-Shifting in Drug Pricing, or the Lack Thereof
Two trade groups representing employers are suggesting that their support of the reconciliation bill’s drug pricing provisions is contingent on employers getting to benefit from any regulatory drug price reductions, not just Medicare. Schaeffer Initiative Expert Loren Adler explores these claims in cost-shifting drug pricing.
Posted in
About this section
On this blog, experts from the USC-Brookings Schaeffer Initiative for Health Policy advance the national health policy conversation through innovative ideas and timely, evidence-based analysis. These posts offer policymakers practical recommendations and analysis for solving the health care issues of today.
More from USC-Brookings Schaeffer on Health Policy Blog
-
Changes in Emergency Physician Service Prices After Connecticut’s 2016 Surprise Billing Law
On January 1, 2022, the No Surprises Act will take effect. This study aims to fill that knowledge gap by presenting preliminary evidence about the effects of Connecticut’s 2016 surprise billing law on the emergency physician services market.
Categorized in -
Options for Containing the Cost of a New Medicare Dental, Hearing, and Vision Benefit
USC-Brookings Schaeffer Initiative for Health Policy expert Matthew Fiedler analyzes options for reducing the cost of adding dental, hearing and vision coverage to Medicare.
Categorized in -
Comments on No Surprises Act Rulemaking: Part I
Schaeffer Initiative experts offer comments on an interim final rule (IFR) issued by the Departments of Health and Human Services, Labor, and the Treasury implementing provisions of the No Surprises Act.
Categorized in -
A Framework for Categorizing and Analyzing Prescription Drug Pricing Reform Options
Schaeffer Initiative experts present a framework for categorizing and analyzing a wide range of proposed policy reforms for prescription drug pricing.
Categorized in -
Government Regulated or Negotiated Drug Prices: Key Design Considerations
Americans pay much higher prices for brand drugs than do people who live in other industrialized nations. Most Americans—79 percent—consider U.S. prescription drug prices to be unreasonable, with almost 3 in 10 reporting they go without prescribed medications because of cost. With 70 percent of Americans reporting that lowering drug costs is their highest healthcare priority, the Congress and the Biden Administration are considering how to lower US drug prices